Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 2/2015

01.03.2015 | Clinical Investigation

Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling

verfasst von: Yoko Okunuki, Kinya Tsubota, Takeshi Kezuka, Hiroshi Goto

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To elucidate the clinical differences between serous retinal detachment (RD)-type and optic disc (OD) swelling-type Vogt-Koyanagi-Harada (VKH) disease.

Methods

We performed a retrospective review of 96 patients with new-onset, active VKH disease. Patients were classified into serous RD-type or OD swelling-type VKH disease groups by means of optical coherence tomography and fluorescein angiography, and the differences between the 2 groups were analyzed.

Results

Eighty-two patients were classified as having RD-type VKH disease (34 men and 48 women, aged 40.5 ± 12.6 years) and 14 patients as having OD swelling-type VKH disease (1 man and 13 women, aged 54.6 ± 11.6 years). Patients with the OD swelling type had older onset (P < 0.001) and were more proportionately female (P = 0.02) than those with the RD type. OD swelling-type VKH disease had a longer interval between disease onset and treatment initiation (22.4 ± 14.0 days vs 12.6 ± 14.7 days; P = 0.02) and a higher frequency of chronic disease (64.3 vs 30.5 %; P = 0.03) than did serous RD-type VKH disease. In the OD swelling type, patients with pretreatment visual acuity (VA) lower than 20/20 developed chronic disease more frequently than did those with VA of 20/20 or better (P = 0.02).

Conclusions

Patients with OD swelling-type VKH disease are more likely to be female, have older onset, and develop chronic disease than patients with RD-type VKH disease. In OD swelling-type VKH disease, worse VA before treatment is associated with the development of chronic disease.
Literatur
1.
Zurück zum Zitat Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(591–9):e591.CrossRef Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(591–9):e591.CrossRef
2.
Zurück zum Zitat Mimura Y. Survey of etiology and diagnosis of Harada’s disease [in Japanese]. Folia Japonica de Ophthalmologica Clinica. 1984;35:2676–83. Mimura Y. Survey of etiology and diagnosis of Harada’s disease [in Japanese]. Folia Japonica de Ophthalmologica Clinica. 1984;35:2676–83.
3.
Zurück zum Zitat Mimura Y, Yuasa T, Bando K, Matsumoto K, Moriyama H. Immunopathological and clinical studies on ocular allergic diseases [in Japanese]. Nihon Ganka Gakkai Zasshi. 1979;83:1909–75.PubMed Mimura Y, Yuasa T, Bando K, Matsumoto K, Moriyama H. Immunopathological and clinical studies on ocular allergic diseases [in Japanese]. Nihon Ganka Gakkai Zasshi. 1979;83:1909–75.PubMed
4.
Zurück zum Zitat Nakao K, Abematsu N, Mizushima Y, Sakamoto T. Optic disc swelling in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2012;53:1917–22.CrossRefPubMed Nakao K, Abematsu N, Mizushima Y, Sakamoto T. Optic disc swelling in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2012;53:1917–22.CrossRefPubMed
5.
Zurück zum Zitat Kiyomoto C, Imaizumi M, Kimoto K, Abe H, Nakano S, Nakatsuka K. Vogt-Koyanagi-Harada disease in elderly Japanese patients. Int Ophthalmol. 2007;27:149–53.CrossRefPubMed Kiyomoto C, Imaizumi M, Kimoto K, Abe H, Nakano S, Nakatsuka K. Vogt-Koyanagi-Harada disease in elderly Japanese patients. Int Ophthalmol. 2007;27:149–53.CrossRefPubMed
6.
Zurück zum Zitat Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–52.CrossRefPubMed Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–52.CrossRefPubMed
7.
Zurück zum Zitat Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27:173–82.CrossRefPubMed Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27:173–82.CrossRefPubMed
8.
Zurück zum Zitat Chee SP, Jap A, Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol. 2009;147(154–61):e1.PubMed Chee SP, Jap A, Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol. 2009;147(154–61):e1.PubMed
9.
Zurück zum Zitat Shima C, Haruta H, Saishin Y, Ohguro N, Tano Y. Significance of corticosteroid pulse-dose therapy in patients with Vogt-Koyanagi-Harada disease [in Japanese]. J Eye. 2008;25:851–4. Shima C, Haruta H, Saishin Y, Ohguro N, Tano Y. Significance of corticosteroid pulse-dose therapy in patients with Vogt-Koyanagi-Harada disease [in Japanese]. J Eye. 2008;25:851–4.
10.
Zurück zum Zitat Chee SP, Jap A, Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol. 2007;27:137–42.CrossRefPubMed Chee SP, Jap A, Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol. 2007;27:137–42.CrossRefPubMed
11.
Zurück zum Zitat Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131:599–606.CrossRefPubMed Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131:599–606.CrossRefPubMed
12.
Zurück zum Zitat Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109:682–7.CrossRefPubMed Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109:682–7.CrossRefPubMed
13.
Zurück zum Zitat Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008;86:902–7.CrossRefPubMed Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008;86:902–7.CrossRefPubMed
14.
Zurück zum Zitat Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–92.CrossRefPubMed Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–92.CrossRefPubMed
15.
Zurück zum Zitat Miyanaga M, Kawaguchi T, Miyata K, Horie S, Mochizuki M, Herbort CP. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol. 2010;54:377–82.CrossRefPubMed Miyanaga M, Kawaguchi T, Miyata K, Horie S, Mochizuki M, Herbort CP. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol. 2010;54:377–82.CrossRefPubMed
16.
Zurück zum Zitat Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Acta Ophthalmol. 1998;116:150–4. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Acta Ophthalmol. 1998;116:150–4.
17.
Zurück zum Zitat Ito YN, Mori K, Young-Duvall J, Yoneya S. Aging changes of the choroidal dye filling pattern in indocyanine green angiography of normal subjects. Retina. 2001;21:237–42.CrossRefPubMed Ito YN, Mori K, Young-Duvall J, Yoneya S. Aging changes of the choroidal dye filling pattern in indocyanine green angiography of normal subjects. Retina. 2001;21:237–42.CrossRefPubMed
18.
Zurück zum Zitat Aota T, Ebisawa N, Maruyama K, Yoneya S. Clinical and indocyanine green angiographic features in aged patients of Vogt-Koyanagi-Harada disease [in Japanese]. Jpn J Clin Ophthalmol. 2003;57:979–83. Aota T, Ebisawa N, Maruyama K, Yoneya S. Clinical and indocyanine green angiographic features in aged patients of Vogt-Koyanagi-Harada disease [in Japanese]. Jpn J Clin Ophthalmol. 2003;57:979–83.
19.
Zurück zum Zitat Rajendram R, Evans M, Khurana RN, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease presenting as optic neuritis. Int Ophthalmol. 2007;27:217–20.CrossRefPubMed Rajendram R, Evans M, Khurana RN, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease presenting as optic neuritis. Int Ophthalmol. 2007;27:217–20.CrossRefPubMed
20.
Zurück zum Zitat Hirata N, Hayashi T, Yamane S, Mizuki N, Takeuchi S. A case of Vogt-Koyanagi-Harada disease with papillitis [in Japanese]. J Eye. 2011;28:293–6. Hirata N, Hayashi T, Yamane S, Mizuki N, Takeuchi S. A case of Vogt-Koyanagi-Harada disease with papillitis [in Japanese]. J Eye. 2011;28:293–6.
Metadaten
Titel
Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling
verfasst von
Yoko Okunuki
Kinya Tsubota
Takeshi Kezuka
Hiroshi Goto
Publikationsdatum
01.03.2015
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 2/2015
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-014-0367-8

Weitere Artikel der Ausgabe 2/2015

Japanese Journal of Ophthalmology 2/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.